Holocene Advisors LP Boosts Stock Position in Chemed Co. (NYSE:CHE)

Holocene Advisors LP raised its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 14.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,470 shares of the company's stock after buying an additional 1,353 shares during the quarter. Holocene Advisors LP owned about 0.07% of Chemed worth $6,292,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Cetera Advisors LLC bought a new stake in shares of Chemed in the 1st quarter worth about $267,000. GAMMA Investing LLC increased its stake in Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company's stock worth $47,000 after acquiring an additional 22 shares during the last quarter. Mather Group LLC. raised its position in Chemed by 60.5% during the second quarter. Mather Group LLC. now owns 183 shares of the company's stock valued at $99,000 after purchasing an additional 69 shares during the period. Harbor Capital Advisors Inc. lifted its stake in shares of Chemed by 292.7% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 1,241 shares of the company's stock valued at $673,000 after purchasing an additional 925 shares during the last quarter. Finally, CWM LLC boosted its holdings in shares of Chemed by 18.5% in the 2nd quarter. CWM LLC now owns 397 shares of the company's stock worth $215,000 after purchasing an additional 62 shares during the period. Institutional investors own 95.85% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Saturday, November 30th. Royal Bank of Canada lowered their target price on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th.

Chemed Trading Down 2.4 %

Shares of NYSE CHE traded down $13.61 during midday trading on Thursday, hitting $555.75. The company's stock had a trading volume of 83,257 shares, compared to its average volume of 85,729. The business's 50 day moving average is $576.77 and its two-hundred day moving average is $565.09. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The firm has a market cap of $8.36 billion, a P/E ratio of 28.79, a price-to-earnings-growth ratio of 2.40 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The business had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the business posted $5.32 earnings per share. On average, analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed's dividend payout ratio is currently 10.11%.

Insider Transactions at Chemed

In other news, EVP Nicholas Michael Westfall sold 1,713 shares of the stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the transaction, the executive vice president now owns 6,109 shares of the company's stock, valued at approximately $3,478,159.15. This represents a 21.90 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now owns 18,287 shares of the company's stock, valued at $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,845 shares of company stock valued at $3,978,798. 3.32% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.